A Shift in Adjuvant Therapy: FDA Approves Nivolumab for Completely Resected Stage IIB/C Melanoma
Immunotherapies, including PD-1 checkpoint inhibitors such as nivolumab, have improved the treatment options for patients with advanced melanoma.
Accurately Recognizing and Diagnosing Psoriasis in Patients With Skin of Color
There may be delays in diagnosis and treatment of psoriasis in patients with darker skin tones due to the clinical presentation variations and less visible erythema.
Differentiating Merkel Cell Carcinoma in Skin of Color
The clinical presentations of Merkel cell carcinoma in patients with skin of color require dermatology providers to be more aware of the nuances in diagnosis and management.
Skin of Color Society Summit: An Overview
Hiring investigators of color, educating and building trust with potential participants, and addressing funding can make clinical trials more diverse.
